Cargando…
Antibody fragments as nanoparticle targeting ligands: a step in the right direction
Recent advances in nanomedicine have shown that dramatic improvements in nanoparticle therapeutics and diagnostics can be achieved through the use of disease specific targeting ligands. Although immunoglobulins have successfully been employed for the generation of actively targeted nanoparticles, th...
Autores principales: | Richards, Daniel A., Maruani, Antoine, Chudasama, Vijay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304706/ https://www.ncbi.nlm.nih.gov/pubmed/28451149 http://dx.doi.org/10.1039/c6sc02403c |
Ejemplares similares
-
Enabling the controlled assembly of antibody conjugates with a loading of two modules without antibody engineering
por: Lee, Maximillian T. W., et al.
Publicado: (2017) -
Forming next-generation antibody–nanoparticle conjugates through the oriented installation of non-engineered antibody fragments
por: Greene, Michelle K., et al.
Publicado: (2017) -
Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones
por: Bahou, Calise, et al.
Publicado: (2018) -
Cysteine-to-lysine transfer antibody fragment conjugation
por: Forte, Nafsika, et al.
Publicado: (2019) -
Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation
por: Castañeda, Lourdes, et al.
Publicado: (2013)